Literature DB >> 32331832

Approach to Diagnosis and Management of Primary Glomerular Diseases Due to Podocytopathies in Adults: Core Curriculum 2020.

Wooin Ahn1, Andrew S Bomback2.   

Abstract

Podocyte injury is the initiating step in the pathway toward clinically evident forms of nephrotic syndrome known as podocytopathies, represented as either minimal change disease (MCD) or focal segmental glomerulosclerosis (FSGS). There are hallmark differences in the histologic appearances of MCD and FSGS, which in turn represent distinct pathogenic models after initial podocyte injury (eg, no change in podocyte number in MCD vs podocyte detachment and death in FSGS). However, MCD and FSGS also share a number of common causes, supporting the theory that these diseases lie along a shared podocytopathy spectrum. In this installment of AJKD's Core Curriculum in Nephrology, we demonstrate how the podocytopathies can be classified according to pathogenesis and treatment response as an alternative to histologic description. Using case examples, we show how these alternative classification schemes can assist not only diagnosis, but also long-term management of podocytopathies.
Copyright © 2020 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Podocytopathy; disease classification; focal segmental glomerulosclerosis (FSGS); minimal change disease (MCD); nephrotic syndrome; review

Mesh:

Year:  2020        PMID: 32331832     DOI: 10.1053/j.ajkd.2019.12.019

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  12 in total

1.  Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study.

Authors:  Ryohei Yamamoto; Enyu Imai; Shoichi Maruyama; Hitoshi Yokoyama; Hitoshi Sugiyama; Asami Takeda; Tatsuo Tsukamoto; Shunya Uchida; Kazuhiko Tsuruya; Tatsuya Shoji; Hiroki Hayashi; Yasuhiro Akai; Megumu Fukunaga; Tsuneo Konta; Saori Nishio; Shunsuke Goto; Hirofumi Tamai; Kojiro Nagai; Ritsuko Katafuchi; Kosuke Masutani; Takashi Wada; Tomoya Nishino; Arimasa Shirasaki; Hiroshi Sobajima; Kosaku Nitta; Kunihiro Yamagata; Junichiro J Kazama; Keiju Hiromura; Hideo Yasuda; Makoto Mizutani; Toshiyuki Akahori; Tomohiko Naruse; Takeyuki Hiramatsu; Kunio Morozumi; Tetsushi Mimura; Yosuke Saka; Eiji Ishimura; Hajime Hasegawa; Daisuke Ichikawa; Takashi Shigematsu; Hiroshi Sato; Ichiei Narita; Yoshitaka Isaka
Journal:  J Nephrol       Date:  2022-04-02       Impact factor: 3.902

2.  Transition from minimal change disease to focal segmental glomerulosclerosis related to occupational exposure: A case report.

Authors:  Long Tang; Zhen Cai; Su-Xia Wang; Wen-Jing Zhao
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

Review 3.  Extracellular Vesicles Released from Stem Cells as a New Therapeutic Strategy for Primary and Secondary Glomerulonephritis.

Authors:  Marco Quaglia; Guido Merlotti; Laura Fornara; Andrea Colombatto; Vincenzo Cantaluppi
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

4.  Unveiling the Features of Mercury-Associated Minimal Change Disease: Comparison with Primary Minimal Change Disease.

Authors:  Ai-Bo Qin; Xiao-Juan Yu; Su-Xia Wang; Fu-de Zhou; Ming-Hui Zhao
Journal:  Kidney Dis (Basel)       Date:  2020-09-29

5.  Visualized podocyte-targeting and focused ultrasound responsive glucocorticoid nano-delivery system against immune-associated nephropathy without glucocorticoid side effect.

Authors:  Kui Fan; Li Zeng; Jing Guo; Shuqin Xie; Yuan Yu; Jianwei Chen; Jin Cao; Qinyanqiu Xiang; Siliang Zhang; Yuanli Luo; Qingyue Deng; Qin Zhou; Yan Zhao; Lan Hao; Zhigang Wang; Ling Zhong
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

6.  Cost-Effectiveness of Targeted Exome Analysis as a Diagnostic Test in Glomerular Diseases.

Authors:  Kushani Jayasinghe; You Wu; Zornitza Stark; Peter G Kerr; Andrew J Mallett; Clara Gaff; Melissa Martyn; Ilias Goranitis; Catherine Quinlan
Journal:  Kidney Int Rep       Date:  2021-09-08

7.  Tetrandrine alleviates podocyte injury via calcium-dependent calpain-1 signaling blockade.

Authors:  Yin Ding; Xuanli Tang; Yuhui Wang; Dongrong Yu; Caifeng Zhu; Jin Yu
Journal:  BMC Complement Med Ther       Date:  2021-12-14

Review 8.  The Pathology Lesion Patterns of Podocytopathies: How and why?

Authors:  Fiammetta Ravaglia; Maria Elena Melica; Maria Lucia Angelotti; Letizia De Chiara; Paola Romagnani; Laura Lasagni
Journal:  Front Cell Dev Biol       Date:  2022-02-24

9.  Lupus podocytopathy and antiphospholipid syndrome in a child with SLE: A case report and literature review.

Authors:  Guo-Min Li; Yi-Fan Li; Qiao-Qian Zeng; Xiao-Mei Zhang; Hai-Mei Liu; Jia-Yan Feng; Yu Shi; Bing-Bing Wu; Hong Xu; Li Sun
Journal:  Front Pediatr       Date:  2022-08-19       Impact factor: 3.569

10.  Spectrum of podocytopathies in new-onset nephrotic syndrome following COVID-19 disease: a report of 2 cases.

Authors:  Rajib K Gupta; Ramya Bhargava; Al-Aman Shaukat; Emily Albert; John Leggat
Journal:  BMC Nephrol       Date:  2020-08-04       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.